ZCA
KITE

Zeke Capital Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Zeke Capital Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,578
Closed -$284K – 629
2017
Q3 		$284K Buy
+1,578
New +$220K 0.04% 347

Zeke Capital Advisors's KITE Position: Q4 2017 in Review

Zeke Capital Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,578 shares — an estimated $284K sold.

Zeke Capital Advisors first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $284K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Zeke Capital Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,578 Kite Pharma, Inc. shares in Q4 2017, an estimated $284K.
  • Zeke Capital Advisors first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Zeke Capital Advisors's Kite Pharma, Inc. position peaked at $284K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Zeke Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.